cbdMD, Inc. (YCBD) Tops Q4 EPS by 27c

cbdMD, Inc. (NYSE: YCBD) reported Q4 EPS of ($0.08), $0.27 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $11.5 million.

For earnings history and earnings-related data on cbdMD, Inc. (YCBD) click here.

You May Also Be Interested In

• cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation
• Morgan Stanley downgrades Chinese luxury auto dealers on weak demand
• Delta Air Lines Q2 earnings preview: softer profit expected amid fuel price headwinds